Mechanisms of human cell-mediated cytotoxicity. II. Correction of the selective defect in natural killing in the Chediak-Higashi syndrome with inducers of intracellular cyclic GMP.
D000328:Adult; D001285:Atropine / Q000494:pharmacology; D003994:Bucladesine / Q000494:pharmacology; D002217:Carbachol / Q000494:pharmacology; D002460:Cell Line; D002470:Cell Survival / Q000187:drug effects; D002609:Chediak-Higashi Syndrome / Q000276:immunology*; D006152:Cyclic GMP / Q000031:analogs & derivatives / Q000378:metabolism* / Q000494:pharmacology; D003602:Cytotoxicity, Immunologic / Q000187:drug effects*; D003995:Dibutyryl Cyclic GMP / Q000037:antagonists & inhibitors / Q000494:pharmacology; D006801:Humans; D007111:Immunity, Cellular / Q000187:drug effects; D007185:Incubators; D007700:Kinetics; D008214:Lymphocytes / Q000145:classification / Q000276:immunology*; D008297:Male
C016276:8-bromocyclic GMP; D003995:Dibutyryl Cyclic GMP; D003994:Bucladesine; D001285:Atropine; D002217:Carbachol; D006152:Cyclic GMP